Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
Diagnosis and Management of Kawasaki Disease - American Family Physician
Clinical Practice Guidelines : Kawasaki disease
Mortality among Children with Kawasaki Disease in Japan | NEJM
Kawasaki Disease An Update of diagnosis and treatment
An Overview of Kawasaki Disease
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría
Mortality among Children with Kawasaki Disease in Japan | NEJM
Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics
Kawasaki Disease: An Update on Diagnosis and Treatment - Pediatrics & Neonatology
Kawasaki Disease: An Update - ppt download
PDF] Treatment Options for Refractory Kawasaki Disease | Semantic Scholar
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the Ame
ADHD-free survival rates for the patients with Kawasaki disease and... | Download Scientific Diagram
Pediatric Diseases:Kawasaki Disease | Treatment of disorder | Tokushukai Group
A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment | American Academy of Pediatrics
Frontiers | Kawasaki Disease | Pediatrics
Refractory Kawasaki disease: diagnostic and management challenges | PHMT